| Literature DB >> 33192601 |
Hyun Jung Park1, Zhenjiang Fan2, Yulong Bai1, Qidong Ren3, Youssef Rbaibi4, Kimberly R Long4, Megan L Gliozzi4, Natalie Rittenhouse5, Joseph D Locker6, Amanda C Poholek5, Ora A Weisz4.
Abstract
Cultured cell models are an essential complement to dissecting kidney proximal tubule (PT) function in health and disease but do not fully recapitulate key features of this nephron segment. We recently determined that culture of opossum kidney (OK) cells under continuous orbital shear stress (OSS) significantly augments their morphological and functional resemblance to PTs in vivo. Here we used RNASeq to identify temporal transcriptional changes upon cell culture under static or shear stress conditions. Comparison of gene expression in cells cultured under static or OSS conditions with a database of rat nephron segment gene expression confirms that OK cells cultured under OSS are more similar to the PT in vivo compared with cells maintained under static conditions. Both improved oxygenation and mechanosensitive stimuli contribute to the enhanced differentiation in these cells, and we identified temporal changes in gene expression of known mechanosensitive targets. We observed changes in mRNA and protein levels of membrane trafficking components that may contribute to the enhanced endocytic capacity of cells cultured under OSS. Our data reveal pathways that may be critical for PT differentiation in vivo and validate the utility of this improved cell culture model as a tool to study PT function.Entities:
Keywords: cell culture; endocytosis; kidney; proximal tubule; shear stress
Year: 2020 PMID: 33192601 PMCID: PMC7662153 DOI: 10.3389/fphys.2020.587358
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
FIGURE 2Temporal gene expression changes in cells exposed to OSS. (A) MDS visualization of the gene expression profiles using IPA comparison analysis (96 h OSS vs. 48 h OSS and 48 h OSS vs. 12 h OSS). IPA Diseases and Biological Function terms that are selectively (B) enriched and (C) de-enriched at later times (96 h OSS vs. 48 h OSS) compared with early times of OK cell culture under OSS (48 h OSS vs. 12 h OSS) are plotted in order of increasing activation z-score.
FIGURE 3Gene expression changes between OSS and static at 96h in reference to 0h static. (A) MDS visualization of the gene expression profiles analyzed using IPA comparison analysis (96 h OSS vs. 0 h Static and 96 h Static vs. 0 h Static). (B) IPA analysis results using Canonical Pathway terms enriched in 96 h OSS vs. 0 h Static. (C) IPA analysis results against Canonical Pathway terms enriched in 96 h Static vs. 0 h Static. [P-value = −log 10(B-H P-value)].
FIGURE 1RNASeq experimental design and analysis on differentially expressed genes. (A) OK cells plated on permeable filter supports and the following day (t = 0 h) transferred to orbital shear stress (OSS) or maintained under static conditions. RNA was harvested at the indicated time points. The images show actin staining (red) and albumin uptake (blue) of cells at 0 h and after 96 h culture under static or OSS conditions. Scale bar: 10 μm. (B) MDS visualization of the three biological replicates from each condition based on their gene expression profiles. The profiles are further grouped by the time point at which the RNA-Seq data were harvested (0, 48, 96 h for static and 12, 48, 96 h for OSS). The number of up- (C) and down- (D) regulated genes in cells exposed to OSS for 48 h vs. 12 h (right circle) and in 96 h vs. 48 h (left circle) with the overlap normalized to 1 in parentheses. The number of up- (E) and down- (F) regulated genes in cells cultured under static conditions for 48 h vs. 0 h (right circle) and for 96 h vs. 48 h (left circle).
Transcripts downregulated after 12 h exposure to OSS.
| Gene | logFC | logCPM | F statistic | FDR | Protein | |
| LRP2BP | –3.5565 | 4.845489 | 335.3451 | 5.22E-08 | 0.000463 | Lrp2 binding protein |
| CA9 | –4.5667 | 3.931135 | 188.9926 | 5.27E-07 | 0.002055 | Carbonic anhydrase IX |
| DHRS9 | –4.5225 | 3.627682 | 124.1449 | 2.79E-06 | 0.003282 | Dehydrogenase/reductase (SDR family) member 9 |
| BLK | –4.7370 | 3.865411 | 123.433 | 2.85E-06 | 0.003282 | B lymphoid kinase |
| SUSD4 | –3.4992 | 3.567026 | 111.0262 | 4.31E-06 | 0.003282 | Sushi domain containing 4 |
| GPR37 | –3.2780 | 2.435743 | 108.3623 | 4.74E-06 | 0.003282 | G protein-coupled receptor 37 |
| ERO1A | –2.0756 | 7.235736 | 95.66971 | 7.67E-06 | 0.003564 | Endoplasmic reticulum oxidoreductase 1 alpha |
| CALML3 | –2.8456 | 6.088465 | 89.46132 | 9.93E-06 | 0.003974 | Calmodulin-like 3 |
| SCARA3 | –2.2841 | 3.424677 | 80.82479 | 1.46E-05 | 0.003983 | Scavenger receptor class A, member 3 |
| ADM | –3.6496 | 5.58256 | 72.16275 | 2.25E-05 | 0.004513 | Adrenomedullin |
| KCNAB2 | –2.7174 | 4.500963 | 65.95435 | 3.15E-05 | 0.005386 | Potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
| KL | –3.5811 | –0.49906 | 65.22774 | 3.28E-05 | 0.005386 | Klotho |
| PKHD1L1 | –2.7306 | 3.91887 | 63.25991 | 3.68E-05 | 0.005509 | Fibrocystin-L; polycystic kidney and hepatic disease 1-like 1 |
| ANGPT1 | –2.0976 | 3.425352 | 56.54254 | 5.57E-05 | 0.006502 | Angiopoietin 1 |
| CPNE5 | –3.7010 | 0.135471 | 56.12173 | 5.72E-05 | 0.006502 | Copine V |
| ST3GAL1 | –2.7728 | 5.076463 | 54.56327 | 6.35E-05 | 0.006773 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
| IGFBP3 | –3.4093 | 5.386319 | 53.92867 | 6.62E-05 | 0.006985 | Insulin-like growth factor binding protein 3 |
| NDRG2 | –2.1087 | 5.667499 | 52.54419 | 7.28E-05 | 0.007118 | N-myc downstream regulated gene 2 |
| ADAMTS13 | –3.2598 | 1.860187 | 50.62773 | 8.33E-05 | 0.007118 | A disintegrin-like and metallopeptidase |
| SPATA17 | –2.0973 | 1.079873 | 48.33872 | 9.85E-05 | 0.007626 | Spermatogenesis associated 17 |
| ENO2 | –2.3957 | 2.921824 | 47.56873 | 0.000104 | 0.007705 | Enolase 2 |
| SPINT1 | –2.2497 | 3.483428 | 47.07817 | 0.000108 | 0.007802 | Serine protease inhibitor, Kunitz type 1 |
| TNFRSF19 | –3.9773 | 0.061145 | 46.90267 | 0.00011 | 0.007823 | Tumor necrosis factor receptor superfamily, member 19 |
| REPS2 | –2.1065 | 4.149959 | 43.27926 | 0.000146 | 0.008666 | RALBP1 associated Eps domain containing protein 2 |
| GRHL3 | –2.5177 | 1.412018 | 42.64034 | 0.000154 | 0.008744 | Grainyhead like transcription factor 3 |
| KCNK13 | –2.6555 | –0.46147 | 42.50643 | 0.000156 | 0.008744 | Potassium channel, subfamily K, member 13 |
| TRIM63 | –2.0653 | 3.552744 | 38.78596 | 0.000215 | 0.010181 | Tripartite motif-containing 63 |
| KANK3 | –2.2144 | 3.613935 | 38.62101 | 0.000218 | 0.010181 | KN motif and ankyrin repeat domains 3 |
| PCSK1 | –3.2134 | 1.50546 | 38.48542 | 0.000221 | 0.010191 | Proprotein convertase subtilisin/kexin type 1 |
| UBA7 | –2.1927 | 1.502012 | 33.93303 | 0.000341 | 0.011741 | Ubiquitin-like modifier activating enzyme 7 |
| LTBP1 | –2.0196 | 2.798 | 33.23028 | 0.000367 | 0.012115 | Latent transforming growth factor beta binding protein 1 |
| SRMS | –2.4056 | 0.549291 | 30.55573 | 0.000486 | 0.013434 | Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites |
| ADGRF5 | –3.4251 | –1.03889 | 29.24985 | 0.000563 | 0.014112 | Adhesion G protein-coupled receptor F5 |
| ANKRD1 | –2.2238 | 0.282321 | 27.70426 | 0.000673 | 0.015169 | Ankyrin repeat domain 1 |
| P2RY6 | –2.312 | –0.75905 | 18.98575 | 0.002214 | 0.025303 | Pyrimidinergic receptor P2Y6 |
| ANKRD37 | –2.97 | 0.438142 | 18.57396 | 0.002364 | 0.026339 | Ankyrin repeat domain 37 |
| TRIM55 | –2.0308 | –0.26692 | 16.5463 | 0.003321 | 0.030642 | Tripartite motif-containing 55 |
| TMEM52B | –2.0286 | 1.403966 | 16.48555 | 0.003356 | 0.03081 | Transmembrane protein 52B |
| CYP4F22 | –3.3780 | –1.37273 | 15.92283 | 0.003708 | 0.032597 | Cytochrome P450 family 4 subfamily F member 22 |
| EFHC2 | –2.0731 | –0.22658 | 14.11734 | 0.005198 | 0.03926 | EF-hand domain (C-terminal) containing 2 |
| ENPP2 | –2.0774 | 4.911872 | 12.37982 | 0.007405 | 0.048088 | Ectonucleotide pyrophosphatase/phosphodiesterase 2 |
IPA Pathway Analysis: 0 h vs. 12 h OSS (selected pathways).
| Category | P-value (range) |
| Organ development | 3E-06-1.98E-02 |
| Tissue morphology | 1.73E-04-1.97E-02 |
| Cellular movement | 1.82E-04-2E-02 |
| Molecular transport | 2.07E-04-1.79E-02 |
| Protein trafficking | 2.07E-04-1.61E-02 |
| Amino acid metabolism | 4.47E-04-1.08E-02 |
| Post-Translational modification | 4.47E-04-1.61E-02 |
| Inflammatory response | 1.37E-03-1.97E-02 |
| Carbohydrate metabolism | 1.8E-03-1.79E-02 |
| Cell cycle | 1.8E-03-1.26E-02 |
| Lipid metabolism | 1.8E-03-1.79E-02 |
| Nucleic acid metabolism | 1.8E-03-8.6E-03 |
| Renal and urological system development and function | 1.8E-03-1.98E-02 |
| Protein folding | 1.43E-02-1.61E-02 |
| Vitamin and mineral metabolism | 1.79E-02-1.79E-02 |
FIGURE 4Similarity of 96 h OSS and 96 h Static to gene expression in microdissected rat nephron segments. tSNE visualization of 96 h OSS and 96 h Static and S1, S2, and S3 rat PT cells from Lee et al. (2015) based on expression information of the genes highly expressed in human and rat nephron segments (see section “Materials and Methods”).
FIGURE 5Culture-dependent temporal gene expression changes in mechanosensitive signaling pathways. Heat maps of the gene expression profile of gene sets defined using keywords (A) TGF-β, (B) Wnt, and (C) MAPK/ERK are plotted for cells incubated for 96, 48, and 0 h under Static conditions or 12, 48, and 96 h under OSS.
FIGURE 6Transcript and protein levels of endocytic traffic proteins in cells cultured under static or OSS conditions. (A) RNA transcript expression (average raw reads) of the genes involved in endocytic traffic in cells cultured for 96 h under static (blue bars) or OSS (red line) conditions is plotted in descending order of expression. (B) Equivalent amounts of lysates from cells cultured for 96h under static (ST) or OSS conditions were blotted with antibodies against Dab2, Dynamin-2 (Dyn), Rab11a, and Caveolin1 (Cav1). The migration of molecular mass markers is shown on the left, and the arrowheads denote the predicted molecular mass of each protein. The asterisk denotes a band also observed in representative blots by the supplier that is presumed to represent a post-translational modification of Rab11a. (C) Band intensities in western blots were quantified and values for 96h OSS (black circles) were normalized to 96 h Static for each protein above (dashed line). Individual values and the mean ± SD of three independent experiments are plotted. *P = 0.029 vs. 96 h Static by one sample t-test.